Table 2. Surrogate markers for coronary heart disease (CHD) shown divided between those with endothelial dysfunction and those without.
| Marker | Normal Microvascular Endothelial Function | Abnormal Microvascular Endothelial Function | p-value |
| Hemoglobin (x1012/L) | 13.43−+1.56 | 13.65−+1.06 | 0.62 |
| Hematocrit (%) | 41.2−+1 | 40.5−+1 | 0.53 |
| Leukocytes (x109/L) | 6.81−+2.96 | 6.11−+1.73 | 0.53 |
| Monocytes (x109/L) | 0.50−+0.13 | 0.51−+0.16 | 0.79 |
| Lymphocytes (x109/L) | 1.74−+0.78 | 1.93−+0.61 | 0.42 |
| Platelets (x109/L) | 225.6−+53.3 | 224.0−+40.4 | 0.92 |
| Total Cholesterol (mg/dL) | 207.1−+53.8 | 183.1−+51.3 | 0.18 |
| LDL-Cholesterol (mg/dL) | 122.6−+40.7 | 101.9−+39.9 | 0.13 |
| HDL-Cholesterol (mg/dL) | 52.2−+14.1 | 57.3−+19.4 | 0.36 |
| Triglycerides (mg/dL) | 156.8−+108.6 | 126.9−+58.8 | 0.31 |
| Glucose (mg/dL) | 105.1−+16.7 | 92.9−+25.8 | 0.09 |
| Insulin (micro IU/ml) | 12.5−+7.9 | 14.0−+9.5 | 0.64 |
| BNP (pg/mL) | 86.6−+78.4 | 181.2−+220.5 | 0.12 |
| Hs-CRP (mg/L) | 4.1−+4.8 | 4.0−+5.6 | 0.97 |
| Homycystein (µmol/L) | 7.1−+1.6 | 8.0−+2.7 | 0.24 |
| Vitamin B12 (ng/L) | 531.8−+273.8 | 357.4−+122.8 | 0.02* |
Only vitamin B12 levels were statistically different.